New approaches to treating diverse bile duct cancers prevalent in southeast Asia

An international study has effectively targeted three distinct groups in cholangiocarcinoma (CCA)—or cancer of the bile duct—with drug inhibitors. These findings, published in the journal Gut, deepen our understanding of the mechanisms that cause CCA to develop and propose new therapeutic targets for this lethal disease. This research is of particular relevance to the Southeast Asian region, where bile duct cancer is endemic.

Leave a Comment

Your email address will not be published. Required fields are marked *

Shopping Cart